propidium has been researched along with sulindac in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, S; Choe, TB; Hong, SI; Jin, HO; Kim, ES; Lee, HC; Lee, SJ; Park, IC; Rhee, CH; Seo, SK; Woo, SH; Yoo, DH | 1 |
Arkusz, J; Ferlińska, M; Gradecka-Meesters, D; Smok-Pieniążek, A; Stańczyk, M; Stępnik, M | 1 |
2 other study(ies) available for propidium and sulindac
Article | Year |
---|---|
Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
Topics: Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Survival; Drug Synergism; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indicators and Reagents; Lung Neoplasms; Membrane Potential, Mitochondrial; Propidium; Sulindac; Tumor Cells, Cultured; Vorinostat | 2008 |
Sulindac and its metabolites: sulindac sulfide and sulindac sulfone enhance cytotoxic effects of arsenic trioxide on leukemic cell lines.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Drug Synergism; Flow Cytometry; HL-60 Cells; Humans; Jurkat Cells; K562 Cells; Lymphocytes; Membrane Potential, Mitochondrial; Mice; NF-kappa B; Oxides; Propidium; Staining and Labeling; Sulindac | 2011 |